Acute Coronary Syndrome (ACS) is an umbrella term that encompasses heart attacks and unstable angina. These conditions are characterized by impaired blood flow to the heart. 

 

ACS is diagnosed by blood tests (for enzymes indicative of dying heart cells) and/or an electrocardiogram.  If a blockage is present, the goal is to eliminate it as rapidly as possible, to minimize the long-term damage to the heart.  

 

As a potential part of this diagnostic procedure, Fibroscint has the added benefit of localizing the blockage.  Rapid localization can aid the diagnosis and planning of treatment, leading to more rapid opening of the effected vasculature.